The FDA has approved Rezdiffra?, the first medication for treating patients with NASH with moderate to advanced liver scarring. Learn more about this new treatment option in the latest #QPS blog post. For info on #obesity, visit https://shorturl.at/ONe0M or email [email protected].?
QPS Holdings, LLC的动态
最相关的动态
-
Wegovy and metformin are two options for patients managing diabetes or seeking weight loss solutions. Here’s a comparison of these medications to help guide your patients. #pharmacy #pharmacist #wegovy #metformin #patientcare #singlecare
要查看或添加评论,请登录
-
This means people in the range of 200-300lbs lost 7-11lbs over a year. So the real world evidence is even more damning as the statistically significant 3.7% weight loss is arguably insignificant clinically. To further consider real world applicability, a 300 pound person could easily lose the same if they cut back on salt and retain less water. That’s an improvement, don’t get me wrong. Maybe even better than fat loss. I continue to believe these drugs are getting way more attention than they deserve. All of this just further points to the massive marketing efforts. People have been convinced they are way more miraculous than they really are.. Entirely unimpressive outcomes for $1000 a month. People needing this weight loss will get 3x the real world results by simple dietary changes— but obviously no one‘s making any money off of that plan. #pharmacy #pharmacist #healthcare #semaglutide #glp https://lnkd.in/gwuVq-2e
要查看或添加评论,请登录
-
Educate Patients About Cough and Cold Product Ingredients: Read the Drug Facts Label to Learn More About OTC Medications. #finance #pharmacy #lifesciences
要查看或添加评论,请登录
-
Common sense implies that if a simple, affordable test is available – which determines in advance - if a medication is going to help you versus cause you harm – most people would choose advance testing. This is especially true when the risks associated with medications are extremely serious or potentially life threatening. Examples: DPYD/DPD deficiency -?Patients with DPD deficiency receiving fluoropyrimidines (5FU, capecitabine) may experience fatal toxicities. HLA -?Patients with specific HLA results receiving abacavir, allopurinol, carbamazepine, oxcarbazepine, phenytoin, fosphenytoin etc. ?– may be predisposed to severe, potentially life-threatening allergic reactions including SJS/TEN. In Canada, the United Kingdom, the Netherlands and other countries - testing prior to receiving fluoropyrimidines is standard of care. This is not true in the US. Pharmacogenetic testing (currently offered by many pharmacists via a painless cheek swab) provides significant information for prescribers and patients regarding the safe optimization of medication selection and dosing. #pharmacists #pharmacogenetics #pgx
要查看或添加评论,请登录
-
GLP-2s, explained GLP-1s and GLP-2s, or glucagon-like peptides, are both secreted from gut endocrine cells and promote nutrient absorption. As medications, they differ vastly. https://buff.ly/3B6iN8p
要查看或添加评论,请登录
-
CASE STUDY 40 Case Study: Beta-Blocker and Asthma Exacerbationa Scenario: A 45-year-old patient with hypertension and mild asthma is prescribed Metoprolol. Shortly after starting the medication, they experience worsening asthma symptoms, including increased wheezing and shortness of breath Assessment: Non-selective beta-blockers can exacerbate asthma by blocking β2-adrenergic receptors in the lungs, leading to bronchoconstriction. Plan: Discontinue Metoprolol and switch to a cardioselective beta-blocker like Atenolol or consider an alternative class of antihypertensives. Educate the patient on the importance of reporting respiratory symptoms when starting new medications. #pharmacology #medicine #pharma #pharmacy
要查看或添加评论,请登录
-
Heart disease includes many diseases that affect your heart, but coronary artery disease (CAD) is the most common and familiar one. CAD can create a waxy buildup in your heart's arteries that can cause a heart attack. Healthy habits, medicines and procedures can prevent or treat CAD and other heart diseases. #nutraceuticals #pharmaceutical #medicine #zodiacpharma #heartdisease #symptoms
要查看或添加评论,请登录
-
-
?? NEW APPROVAL: The FDA has approved BIMZELX? (bimekizumab-bkzx) HCP from UCB for adults with moderate-to-severe hidradenitis suppurativa (HS), making it the first treatment to selectively inhibit both interleukin 17A (IL-17A) and interleukin 17F (IL-17F). https://lnkd.in/e6tdnVch
要查看或添加评论,请登录
-
Familiar Scene for PepGen as FDA Puts a Hold on DMD Medicationimg class="aligncenter" src="https://lnkd.in/e9it_dKr" alt="Familiar Scene for PepGen as FDA Puts a Hold on DMD Medication" / https://lnkd.in/e7uJx2H7
要查看或添加评论,请登录
-
Are you looking for information on GLP-1 medications? We are asked about them all the time and what form they may be available. To help, we have put together an introductory overview so our patients can be more informed. Check it out for yourself!
要查看或添加评论,请登录